Cargando…
Young Women’s Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa
End-user input is critical to inform development of multipurpose prevention technology (MPT) products that prevent HIV and pregnancy. The TRIO Study, conducted in Kenya and South Africa, enrolled 277 HIV-negative women aged 18–30 in a randomized cross-over study to use each placebo MPT (daily oral t...
Autores principales: | Minnis, Alexandra M., Roberts, Sarah T., Agot, Kawango, Weinrib, Rachel, Ahmed, Khatija, Manenzhe, Kgahlisho, Owino, Fredrick, van der Straten, Ariane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097726/ https://www.ncbi.nlm.nih.gov/pubmed/29560570 http://dx.doi.org/10.1007/s10461-018-2078-5 |
Ejemplares similares
-
End-Users’ Product Preference Across Three Multipurpose Prevention Technology Delivery Forms: Baseline Results from Young Women in Kenya and South Africa
por: Weinrib, Rachel, et al.
Publicado: (2017) -
The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention
por: van der Straten, Ariane, et al.
Publicado: (2018) -
“We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study
por: Shapley-Quinn, Mary Kate, et al.
Publicado: (2019) -
Female and male partner perspectives on placebo Multipurpose Prevention Technologies (MPTs) used by women in the TRIO study in South Africa and Kenya
por: Wagner, Laura Danielle, et al.
Publicado: (2022) -
Engaging study participants in interpreting results: lessons from the TRIO study in Kenya and South Africa
por: Agot, Kawango, et al.
Publicado: (2019)